Home THERAPY AREAS Emerging opportunities and challenges in SHPT 18 February 2022 Nephrology and Rare Diseases CKD-MBD and SHPT SHPT is a common and serious complication of CKD that, if left untreated, increases the risk of bone and cardiovascular disease. However, historically there is little consensus about the optimal management of SHPT in patients with ND-CKD. Read this ‘Stay updated’ feature, which provides expert insights into SHPT and its pathogenesis, to learn more about the current challenges and opportunities in the management of SHPT. View PDF